1 / 32

A NCA disease: pathology

A NCA disease: pathology. D ušan F erluga Institute of Pathology, Faculty of Medicine, University of Ljubljana Ljubljana, Slovenia. S ystemic vasculitides. International Consensus Conference , Chapel Hill, USA, 1993 ( proposal in Arthritis&Rheumatism 1994, 37: 187-192)

elata
Download Presentation

A NCA disease: pathology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. ANCAdisease: pathology Dušan Ferluga Institute of Pathology, Faculty of Medicine, University of Ljubljana Ljubljana, Slovenia

  2. Systemic vasculitides International Consensus Conference, Chapel Hill,USA, 1993 (proposal in Arthritis&Rheumatism 1994,37: 187-192) - Terminology (names of diseases = diagnostic terms) - Definition of diseases (abnormalities that warrant assignement of the diagnostic terms) - Diagnostic criteria? (not yet defined)

  3. Small vessel vasculitides • Frequent affection of kidneys (up to 100%)Glomerulonephritis, extraglomerular vasculitis, tubulointerstitial involvement • Important contribution of kidney biopsy to establish diagnosis and to evaluate activity, chronicity and severity (extent) • Final diagnosis clinical (immunoserology!)-pathological

  4. Necrotizingcrescentic glomerulonephritis (NC-GN) • Focal (<50%) or diffuse (>50%) • Isolated (primary), in systemic vasculitides, in autoimmune connective tissuee diseases • Immunopathogenetic categories:1. Immune complex NC-GN 98/285 – 34,4%2. Anti-GBM NC-GN 40/285 – 14,0% 3. Pauci-immune ANCA NC-GN 147/285 – 51,6%

  5. Significance of kidney biopsy in ANCA disease To confirm diagnosis - why? ANCA specificity and sensitivity are not absolute. Not all ANCA positive patients have ANCA vasculitis and ANCA negative results do not exclude ANCA disease.

  6. Histopathologic hallmarks of ANCA glomerulonephritis / vasculitis • Pauci-immune pattern by immunofluorescence • Fibrinoid necrosis • Extracapillary crescents without significant glomerular proliferation • Residual scarring glomerulosclerosis (segmental, global)

  7. CD68

  8. Clinico-pathologic diagnosis in 135 patients with ANCA renal disease

  9. Significance of kidney biopsy in differential diagnosis of ANCA vasculitides • Underdiagnosed extraglomerular focal necrotizing vasculitis (5 - 35%), suggesting systemic vasculitides, because of biopsy sampling inspite of serial sections • Limited significance of kidney biopsy in distinguishing between MPA, WG and CS (limited specificities of eosinophilic infiltration, absence of true interstitial geographic type granulomas as typically seen in respiratory tract)

  10. Renal histologic changes in 135 patients with ANCA-associated GN

  11. Selected demographic and clinical data of 135 patients with ANCA-associated GN

  12. Comparison of histologic changes in the first renal biopsy and rebiopsies of 38 patients with ANCA vasculitis

  13. Significance of kidney biopsy in ANCA disease • Major significance for planning therapy, monitoring response and detecting recurrences.Pathologist has to provide exact information – quantitative data about active therapeutically accesible lesions (necrotizing, crescentic), about irreversible chronic sclerotic changes, as well as about preserved nephrons.

  14. Biopsyreportschemafor ANCA glomerulonephritis (GN) 1. Focal (≤50%; indicating percentage of normal glomeruli) 1.1. Focal active (A): necrosis (%), crescents (%: cellular, fibrocellular)1.2. Focal chronic (C): sclerosis – global (%), segmental (%), crescents (%: fibrous)1.3. Focal active and chronic (A/C): as in 1.1+1.2. 2.Diffuse (≥50%; indicating percentage of normal glomeruli)2.1. Diffuse active (A): necrosis (%), crescents (%: cellular, fibrocellular)2.2. Diffuse chronic (C): sclerosis – global (%), segmental (%), crescents (%: fibrous)2.3. Diffuse active and chronic (A/C): as in 2.1+2.2____________________________________________________________________ *Inclusion criteria: pauci-immune GN and ≥1 glomerulus with necrosis and/or crescent (cellular, fibrocellular, fibrous) in all six classes____________________________________________________________________ (Ferluga D. et al. 1st MCP, Ohrid 2011)

  15. Collaborators and contributors Alenka Vizjak (immunopathology) Anastazija Hvala (electron microscopy) Jelka Lindič (nephrology)

More Related